Cargando…

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1

All possible direct-acting antiviral agent (DAA) regimens for treatment-naive hepatitis C genotype 1 were evaluated by many randomized controlled trials (RCTs). However, the optimum regimen remains inconclusive. We aim to compare interventions in terms of sustained virological response at 12 (SVR12)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Gui-Qi, Zou, Zhuo-Lin, Zheng, Ji-Na, Chen, Da-Zhi, Zou, Tian-Tian, Shi, Ke-Qing, Zheng, Ming-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782908/ https://www.ncbi.nlm.nih.gov/pubmed/26945424 http://dx.doi.org/10.1097/MD.0000000000003004

Ejemplares similares

Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective study
por: Li, Juan, et al.
Publicado: (2020)

Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients
por: Liu, Yen-Chun, et al.
Publicado: (2020)

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents
por: Chen, Yen-Chun, et al.
Publicado: (2020)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents
por: Huang, Chao-Min, et al.
Publicado: (2017)

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients
por: Li, Min-Ran, et al.
Publicado: (2016)

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2020)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients
por: Asil, Mehmet, et al.
Publicado: (2016)

Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults: A Large Population-Based Study
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases
por: Deng, Yong-Qiong, et al.
Publicado: (2015)

Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China
por: Li, Zhao, et al.
Publicado: (2017)

Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
por: Zanaga, L.P., et al.
Publicado: (2016)

Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus
por: Wang, Ye, et al.
Publicado: (2015)

Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
por: Seo, Yeon Seok, et al.
Publicado: (2016)

Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis
por: Suwanthawornkul, Thanthima, et al.
Publicado: (2015)

Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
por: Tsai, Pei-Chien, et al.
Publicado: (2017)

Establishment and Validation of ALPH-Q Score to Predict Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Cohort Study
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)

Association of Glutathione S-Transferase M1 null genotype with inflammatory bowel diseases: A systematic review and meta-analysis
por: Zhou, Yu-Jie, et al.
Publicado: (2019)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients
por: Li, Zhanyi, et al.
Publicado: (2017)

An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study
por: Chon, Young Eun, et al.
Publicado: (2016)

Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
por: Lee, Hyun Woong, et al.
Publicado: (2017)

Surgical treatment of acute calculous cholecystitis complicated with hepatic dysfunction
por: Tian, Yuanhu, et al.
Publicado: (2020)

The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis: A systematic review and meta-analysis
por: Zhang, Chi, et al.
Publicado: (2019)

The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element
por: Guo, Yanan, et al.
Publicado: (2019)

Up-regulation of Plasma Hexosylceramide (d18:1/18:1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort Study
por: Zhang, Jin-Yan, et al.
Publicado: (2016)

Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation: A case report and literature review
por: Guan, Haitao, et al.
Publicado: (2017)

Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China
por: Shen, Yinzhong, et al.
Publicado: (2015)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Rupture of hepatic hemangioma with hemoperitoneum due to spontaneous gallbladder perforation: A unique case report
por: Ke, Qing-Hong, et al.
Publicado: (2017)

Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks: A retrospective observational study
por: Zhang, Yafei, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

Clinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study
por: Cha, Ra Ri, et al.
Publicado: (2016)

A case report of sofosbuvir and daclatasvirto treat a patient with acute hepatitis C virus genotype 2 monoinfection
por: Li, Chen, et al.
Publicado: (2018)

Management of hepatitis C genotype 4 in the directly acting antivirals era
por: Hathorn, Emma, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_onnji7vdmfasr36oi7mg41u4dr